FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319335912> ?p ?o ?g. }

• W4319335912 abstract "There is considerable potential for integrating transarterial chemoembolization (TACE), programmed death-(ligand)1 (PD-[L]1) inhibitors, and molecular targeted treatments (MTT) in hepatocellular carcinoma (HCC). It is necessary to investigate the therapeutic efficacy and safety of TACE combined with PD-(L)1 inhibitors and MTT in real-world situations. In this nationwide, retrospective, cohort study, 826 HCC patients receiving either TACE plus PD-(L)1 blockades and MTT (combination group, n = 376) or TACE monotherapy (monotherapy group, n = 450) were included from January 2018 to May 2021. The primary endpoint was progression-free survival (PFS) according to modified RECIST. The secondary outcomes included overall survival (OS), objective response rate (ORR), and safety. We performed propensity score matching approaches to reduce bias between two groups. After matching, 228 pairs were included with a predominantly advanced disease population. Median PFS in combination group was 9.5 months (95% confidence interval [CI], 8.4-11.0) versus 8.0 months (95% CI, 6.6-9.5) (adjusted hazard ratio [HR], 0.70, P = 0.002). OS and ORR were also significantly higher in combination group (median OS, 19.2 [16.1-27.3] vs. 15.7 months [13.0-20.2]; adjusted HR, 0.63, P = 0.001; ORR, 60.1% vs. 32.0%; P < 0.001). Grade 3/4 adverse events were observed at a rate of 15.8% and 7.5% in combination and monotherapy groups, respectively. Our results suggest that TACE plus PD-(L)1 blockades and MTT could significantly improve PFS, OS, and ORR versus TACE monotherapy for Chinese patients with predominantly advanced HCC in real-world practice, with an acceptable safety profile." @default.
• W4319335912 created "2023-02-08" @default.
• W4319335912 creator A5000417436 @default.
• W4319335912 creator A5000731922 @default.
• W4319335912 creator A5001097432 @default.
• W4319335912 creator A5001103132 @default.
• W4319335912 creator A5002559594 @default.
• W4319335912 creator A5005426960 @default.
• W4319335912 creator A5005900235 @default.
• W4319335912 creator A5006105564 @default.
• W4319335912 creator A5006429727 @default.
• W4319335912 creator A5006652481 @default.
• W4319335912 creator A5008010309 @default.
• W4319335912 creator A5010407734 @default.
• W4319335912 creator A5013949576 @default.
• W4319335912 creator A5014510012 @default.
• W4319335912 creator A5018725689 @default.
• W4319335912 creator A5020138539 @default.
• W4319335912 creator A5021798748 @default.
• W4319335912 creator A5025110438 @default.
• W4319335912 creator A5025619971 @default.
• W4319335912 creator A5026777262 @default.
• W4319335912 creator A5027041701 @default.
• W4319335912 creator A5027797567 @default.
• W4319335912 creator A5028479077 @default.
• W4319335912 creator A5028600179 @default.
• W4319335912 creator A5029368153 @default.
• W4319335912 creator A5030403651 @default.
• W4319335912 creator A5032001090 @default.
• W4319335912 creator A5032764121 @default.
• W4319335912 creator A5033707375 @default.
• W4319335912 creator A5033729673 @default.
• W4319335912 creator A5035040569 @default.
• W4319335912 creator A5036574239 @default.
• W4319335912 creator A5039320907 @default.
• W4319335912 creator A5041279047 @default.
• W4319335912 creator A5041474539 @default.
• W4319335912 creator A5041512369 @default.
• W4319335912 creator A5042397011 @default.
• W4319335912 creator A5045216454 @default.
• W4319335912 creator A5045476074 @default.
• W4319335912 creator A5045494854 @default.
• W4319335912 creator A5045842939 @default.
• W4319335912 creator A5045964936 @default.
• W4319335912 creator A5046136378 @default.
• W4319335912 creator A5046340312 @default.
• W4319335912 creator A5047234655 @default.
• W4319335912 creator A5050064941 @default.
• W4319335912 creator A5050319187 @default.
• W4319335912 creator A5051591723 @default.
• W4319335912 creator A5051691879 @default.
• W4319335912 creator A5053894247 @default.
• W4319335912 creator A5054303822 @default.
• W4319335912 creator A5057069179 @default.
• W4319335912 creator A5057450868 @default.
• W4319335912 creator A5060021711 @default.
• W4319335912 creator A5061951696 @default.
• W4319335912 creator A5066637894 @default.
• W4319335912 creator A5067814400 @default.
• W4319335912 creator A5071615222 @default.
• W4319335912 creator A5073108755 @default.
• W4319335912 creator A5074406685 @default.
• W4319335912 creator A5077397027 @default.
• W4319335912 creator A5078602309 @default.
• W4319335912 creator A5085462851 @default.
• W4319335912 creator A5091561251 @default.
• W4319335912 date "2023-02-08" @default.
• W4319335912 modified "2023-10-17" @default.
• W4319335912 title "Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)" @default.
• W4319335912 cites W1971837077 @default.
• W4319335912 cites W1994193851 @default.
• W4319335912 cites W2028319026 @default.
• W4319335912 cites W2096137222 @default.
• W4319335912 cites W2147532376 @default.
• W4319335912 cites W2179283632 @default.
• W4319335912 cites W2277004004 @default.
• W4319335912 cites W2500954855 @default.
• W4319335912 cites W2560499218 @default.
• W4319335912 cites W2606367731 @default.
• W4319335912 cites W2779300477 @default.
• W4319335912 cites W2787358630 @default.
• W4319335912 cites W2791328450 @default.
• W4319335912 cites W2792376809 @default.
• W4319335912 cites W2796067155 @default.
• W4319335912 cites W2805592007 @default.
• W4319335912 cites W2888049100 @default.
• W4319335912 cites W2888394278 @default.
• W4319335912 cites W2990602950 @default.
• W4319335912 cites W3008514541 @default.
• W4319335912 cites W3025022288 @default.
• W4319335912 cites W3026099517 @default.
• W4319335912 cites W3045387409 @default.
• W4319335912 cites W3082221098 @default.
• W4319335912 cites W3094602125 @default.
• W4319335912 cites W3099108820 @default.
• W4319335912 cites W3111804968 @default.
• W4319335912 cites W3119005666 @default.
• W4319335912 cites W3121807241 @default.
• W4319335912 cites W3161525867 @default.
• W4319335912 cites W3166753505 @default.

• next